-
This WhiteFiber Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Friday
2026 Apr 10, 7:15am | 447Read More...Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. BTIG analyst Gregory Lewis initiated coverage on WhiteFiber Inc (NASDAQ:WYFI) with a Buy rating...
-
This Equinix Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
2026 Apr 09, 10:17am | 492Read More...Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Morgan Stanley analyst Carlos De Alba initiated coverage on NovaGold Resources Inc (AMEX:NG)...
-
MapLight's Psychosis Drug Could Deliver Billion-Dollar Upside, Says Analyst
2026 Apr 08, 2:29pm | 619Read More...Needham initiated coverage on MapLight Therapeutics Inc. (NASDAQ:MPLT). The company, which is focused on central nervous system disorders, debuted on NASDAQ in October 2025 and raised $296.3 million in IPO gross proceeds. • MapLight Therapeutics stock is showing positive momentum. What...
- Array
-
Summit Therapeutics Has Scarcity Value In A Crowded Drug Race: Analyst
2026 Apr 08, 2:27pm | 771Read More...Stifel on Tuesday initiated coverage of Summit Therapeutics Inc. (NASDAQ:SMMT), citing the potential of its lead drug candidate, ivonescimab. Ivonescimab is a PD-1xVEGF bispecific antibody under development for cancer, primarily for lung cancer. Extensive Phase 3 Pipeline Strengthens Positioning...
-
This Inhibrx Biosciences Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Wednesday
2026 Apr 08, 9:25am | 456Read More...Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Stifel analyst Dara Azar initiated coverage on Inhibrx Biosciences Inc (NASDAQ:INBX) with a Buy...
-
This National Fuel Gas Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
2026 Apr 07, 7:44am | 549Read More...Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Goldman Sachs analyst Makoto Kuroda initiated coverage on PayPay Corporation (NASDAQ:PAYP) with...
-
PayPay To Generate 'Outsized Earnings Growth' For 5-10 Years: Analysts
2026 Apr 06, 11:06am | 362Read More...Tokyo-based electronic payment company PayPay Corp (NASDAQ:PAYP) made its US stock market debut on March 12. Here are the key analyst insights: Benchmark analyst Mark Palmer initiated coverage with a Buy rating and price target of $31. Cantor Fitzgerald analyst Ryan Campbell began coverage with an...
-
This Avalo Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
2026 Apr 06, 8:49am | 536Read More...Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Mizuho analyst Dan Dolev initiated coverage on PayPay Corp – ADR (NASDAQ:PAYP) with an...
-
What's Going On With Netflix Stock Thursday?
2026 Apr 02, 11:55am | 532Read More...Netflix Inc. (NASDAQ:NFLX) shares moved higher Thursday as investors positioned ahead of the company's April 16 earnings report. Attention is centered on Netflix's monetization drivers, including ad growth and discovery-led engagement. Citizens initiated coverage with a Market Perform rating,...
-
This Nutanix Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
2026 Apr 02, 11:27am | 544Read More...Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. BTIG analyst Andre Madrid initiated coverage on StandardAero, Inc. (NYSE:SARO) with a Buy...
-
Diabetes Focused MiniMed Recovery Story Builds As Pipeline Improves
2026 Apr 01, 10:15am | 762Read More...William Blair on Tuesday initiated coverage on MiniMed Group Inc. (NASDAQ:MMED), a pure-play diabetes devices company. MiniMed's Competitive Setbacks And Strategic Reset William Blair analyst Steven Lichtman said MiniMed, a unit of Medtronic Plc (NYSE:MDT), lost its U.S. insulin pump leadership...
-
This Sensata Technologies Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
2026 Apr 01, 10:08am | 541Read More...Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Baird analyst Daniel Moore initiated coverage on Materion Corporation (NYSE:MTRN) with an...
-
Docusign: Fiscal 2027 Could Be 'Transition Year' Despite Double Digit Growth Strategy
2026 Mar 31, 12:06pm | 263Read More...While Docusign Inc (NASDAQ:DOCU) seems to have the right strategy to generate double-digit growth in the long term, fiscal 2027 is likely to be "a transition year" for the company, according to BofA Securities. The Docusign Analyst: Analyst Matt Bullock reinstated coverage with an Underperform...
-
HubSpot Poised For Growth? Analyst Targets $300 Amid AI, Pricing Momentum
2026 Mar 31, 12:05pm | 282Read More...HubSpot Inc (NYSE:HUBS) seems well-positioned to reaccelerate growth to 20% in the back half of 2026, according to BofA Securities analyst Matt Bullock. The HubSpot Analyst: Bullock reinstated coverage of the cloud-based customer relationship management (CRM) platform with a Buy rating and price...
-
This NiSource Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Tuesday
2026 Mar 31, 7:57am | 387Read More...Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. BTIG analyst Marie Thibault initiated coverage on Minimed Group, Inc. (NASDAQ:MMED) with a Buy...
















